Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnostic Ability of a Smartphone App for Dry Eye Disease: Protocol for a Multicenter, Open-Label, Prospective, and Cross-sectional Study.
Nagino K, Okumura Y, Yamaguchi M, Sung J, Nagao M, Fujio K, Akasaki Y, Huang T, Hirosawa K, Iwagami M, Midorikawa-Inomata A, Fujimoto K, Eguchi A, Okajima Y, Kakisu K, Tei Y, Yamaguchi T, Tomida D, Fukui M, Yagi-Yaguchi Y, Hori Y, Shimazaki J, Nojiri S, Morooka Y, Yee A, Miura M, Ohno M, Inomata T. Nagino K, et al. Among authors: tei y. JMIR Res Protoc. 2023 Mar 13;12:e45218. doi: 10.2196/45218. JMIR Res Protoc. 2023. PMID: 36912872 Free PMC article.
Prognostic value of pre-treatment risk stratification and post-treatment neutrophil/lymphocyte ratio change for pembrolizumab in patients with advanced urothelial carcinoma.
Yamamoto Y, Yatsuda J, Shimokawa M, Fuji N, Aoki A, Sakano S, Yamamoto M, Suga A, Tei Y, Yoshihiro S, Kitahara S, Nagao K, Takai K, Kamiryo Y, Akao J, Yamaguchi S, Oba K, Shimabukuro T, Matsumoto H, Kamba T, Matsuyama H. Yamamoto Y, et al. Among authors: tei y. Int J Clin Oncol. 2021 Jan;26(1):169-177. doi: 10.1007/s10147-020-01784-w. Epub 2020 Sep 18. Int J Clin Oncol. 2021. PMID: 32948925
A combination of routine laboratory findings and vital signs can predict survival of advanced cancer patients without physician evaluation: a fractional polynomial model.
Hamano J, Takeuchi A, Yamaguchi T, Baba M, Imai K, Ikenaga M, Matsumoto Y, Sekine R, Yamaguchi T, Hirohashi T, Tajima T, Tatara R, Watanabe H, Otani H, Nagaoka H, Mori M, Tei Y, Hiramoto S, Morita T. Hamano J, et al. Among authors: tei y. Eur J Cancer. 2018 Dec;105:50-60. doi: 10.1016/j.ejca.2018.09.037. Epub 2018 Nov 2. Eur J Cancer. 2018. PMID: 30391780
Identification of curable high-risk prostate cancer using radical prostatectomy alone: who are the good candidates for undergoing radical prostatectomy among patients with high-risk prostate cancer?
Nagao K, Matsuyama H, Matsumoto H, Nasu T, Yamamoto M, Kamiryo Y, Baba Y, Suga A, Tei Y, Yoshihiro S, Aoki A, Shimabukuro T, Joko K, Sakano S, Takai K, Yamaguchi S, Akao J, Kitahara S; Yamaguchi Uro-Oncology Group. Nagao K, et al. Among authors: tei y. Int J Clin Oncol. 2018 Aug;23(4):757-764. doi: 10.1007/s10147-018-1272-9. Epub 2018 Mar 27. Int J Clin Oncol. 2018. PMID: 29589154 Free PMC article.
76 results